COMPANY · NIPC 508512409

TAKEDA FARMACEUTICOS PORTUGAL LDA

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €1,165,674.78 across 33 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameTAKEDA FARMACEUTICOS PORTUGAL LDA
NIPC508512409

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2014 to 2025. The table below gives the same values.2014: €26,60020142015: €11,0442016: €70,405.5020162017: €297,6892018: €155,86420182019: €292,417.922020: €5,52220202022: €153,128.222025: €153,004.142025€297,689
Contracted value by year
YearContractsContract value
20141€26,600
20151€11,044
20163€70,405.50
20173€297,689
20186€155,864
201912€292,417.92
20201€5,522
20221€153,128.22
20255€153,004.14
Contracted value by place of performance
NameContractsContract value
Porto20€727,131.72
Loures1€153,128.22
Almada2€78,603.28
Leiria1€64,095.36
Matosinhos2€52,829.50
Funchal2€44,176
Faro2€25,405.20
Santo Tirso2€10,305.50
Vila Nova de Famalicão2€10,305.50
Lisboa1€10,000
Largest contracts
SubjectYearContract value
Aquisição de medicamentos - Fibrinogénio humano e Brentuximab vedotina2017€161,932
Diversos ao Abrigo do Acordo Quadro 2021/62022€153,128.22
Aquisição de medicamentos - Brentuximab vedotina, Cinchocaína e Fibrinogénio humano2017€125,757
Aquisição de medicamentos - Brentuximab vedotina e Fibrinogénio humano2019€97,766
1232/2024 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/438 - Derivados do plasma humano e 2023/671 - Medicamentos diversos para aquisição de medicamentos derivados do plasma2025€73,499

Who they competed with

In 3 contracts with a list of competitors, the company took part and was awarded 3 (100%).

Companies with the most procedures in common
CompanyProcedures in common
GRIFOLS PORTUGAL, LDA.1
TAKEDA-FARMACEUTICOS PORTUGAL, LDA1
OCTAPHARMA, PRODUTOS FARMACÊUTICOS, LDA.1
CSL BEHRING, LDA1
KEDRION BIOPHARMA GMBH-SUCURSAL PORTUGAL1

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents11 companies and 13 links. The list below gives the same content as text.NIPC 500063524 (NIPC 500063524)NIPC 500063524NIPC 500220913 (NIPC 500220913)NIPC 500220913NIPC 500233810 (NIPC 500233810)NIPC 500233810GRIFOLS PORTUG… (NIPC 502041285)GRIFOLS PORTUG…TAKEDA-FARMACE… (NIPC 502801204)TAKEDA-FARMACE…OCTAPHARMA, PR… (NIPC 502820780)OCTAPHARMA, PR…CSL BEHRING, L… (NIPC 503047201)CSL BEHRING, L…NIPC 503347345 (NIPC 503347345)NIPC 503347345NIPC 508512409 (NIPC 508512409)NIPC 508512409NIPC 508622263 (NIPC 508622263)NIPC 508622263KEDRION BIOPHA… (NIPC 980701996)KEDRION BIOPHA…

Dotted: competed in the same procedure. Dotted: same procedure.

1 more links

Investigations that mention it

No published investigation mentions this company by NIPC.